Korean J Hematol.  2011 Dec;46(4):287-288. 10.5045/kjh.2011.46.4.287.

The role of B cells in acute graft-versus-host disease

• Cho BS
• Chung NG

• KMID: 2251992
• DOI: http://doi.org/10.5045/kjh.2011.46.4.287

Abstract

No abstract available.

MeSH Terms

B-Lymphocytes
Graft vs Host Disease

Reference

1. Sarantopoulos S, Stevenson KE, Kim HT, et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood. 2009; 113:3865–3874. PMID: 19168788.

2. Kim JS, Kim SJ, Cheong JW, et al. Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Korean J Hematol. 2011; 46:175–179. PMID: 22065972.

3. Walters S, Webster KE, Sutherland A, et al. Increased CD4+ Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol. 2009; 182:793–801. PMID: 19124722.

4. Mackay F, Leung H. The role of the BAFF/APRIL system on T cell function. Semin Immunol. 2006; 18:284–289. PMID: 16931039.

5. Cho BS, Min CK, Kim HJ, et al. High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2010; 16:629–638. PMID: 19963070.